Ontology highlight
ABSTRACT:
SUBMITTER: Bassiony S
PROVIDER: S-EPMC7524184 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Bassiony Sarah S Harrison Claire N CN McLornan Donal P DP
Therapeutics and clinical risk management 20200925
Myelofibrosis is a heterogeneous disorder with regard to both molecular pathogenesis and clinical phenotype, ranging from an initial fairly indolent condition in some through to an aggressive and debilitating scenario with profound constitutional symptoms, cytopenia frequently requiring transfusional support, and massive splenomegaly. Many advances have been made within the therapeutic arena, and an increasing array of novel agents are now available for disease management. Within this review, we ...[more]